Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022.
Tobacco use is a risk factor for many chronic health conditions. Quantifying burden of tobacco use among people with tobacco-related illnesses (TRI) can strengthen cessation programs. This study estimated prevalence, patterns and correlates of tobacco use among patients with TRI at four national ref...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLOS Global Public Health |
| Online Access: | https://doi.org/10.1371/journal.pgph.0002002 |
| _version_ | 1827761977817038848 |
|---|---|
| author | Valerian Mwenda Lazarus Odeny Shukri Mohamed Gladwell Gathecha Anne Kendagor Dorcas Kiptui Florence Jaguga Beatrice Mugi Caroline Mithi Kennedy Okinda Daniel Mwai David Njuguna Winnie Awuor Rachel Kitonyo-Devotsu Jane Rahedi Ong'ang'o |
| author_facet | Valerian Mwenda Lazarus Odeny Shukri Mohamed Gladwell Gathecha Anne Kendagor Dorcas Kiptui Florence Jaguga Beatrice Mugi Caroline Mithi Kennedy Okinda Daniel Mwai David Njuguna Winnie Awuor Rachel Kitonyo-Devotsu Jane Rahedi Ong'ang'o |
| author_sort | Valerian Mwenda |
| collection | DOAJ |
| description | Tobacco use is a risk factor for many chronic health conditions. Quantifying burden of tobacco use among people with tobacco-related illnesses (TRI) can strengthen cessation programs. This study estimated prevalence, patterns and correlates of tobacco use among patients with TRI at four national referral hospitals in Kenya. We conducted a cross-sectional study among patients with five TRI (cancer, cardiovascular diseases, cerebrovascular disease, chronic obstructive pulmonary disease, and pulmonary tuberculosis) during January-July 2022. Cases identified from medical records were interviewed on socio-demographic, tobacco use and cessation information. Descriptive statistics were used to characterize patterns of tobacco use. Multiple logistic regression models were used to identify associations with tobacco use. We identified 2,032 individuals with TRI; 46% (939/2,032) had age ≥60 years, and 61% (1,241/2,032) were male. About 45% (923/2,032) were ever tobacco users (6% percent current and 39% former tobacco users). Approximately half of smokers and 58% of smokeless tobacco users had attempted quitting in the last month; 42% through cessation counselling. Comorbidities were present in 28% of the participants. Most (92%) of the patients had been diagnosed with TRI within the previous five years. The most frequent TRI were oral pharyngeal cancer (36% [725/2,032]), nasopharyngeal cancer (12% [246/2.032]) and lung cancer (10% [202/2,032]). Patients >60 years (aOR 2.24, 95% CI: 1.84, 2.73) and unmarried (aOR 1.21, 95% CI: 1.03, 1.42) had higher odds of tobacco use. Female patients (aOR 0.35, 95% CI: 0.30, 0.41) and those with no history of alcohol use (aOR 0.27, 95% CI: 0.23, 0.31), had less odds of tobacco use. Our study shows high prevalence of tobacco use among patients with TRI in Kenya, especially among older, male, less educated, unmarried, and alcohol users. We recommend tobacco use screening and cessation programs among patients with TRI as part of clinical care. |
| first_indexed | 2024-03-11T10:22:27Z |
| format | Article |
| id | doaj.art-36dba366ee2347688b6b0d6e76b6e69f |
| institution | Directory Open Access Journal |
| issn | 2767-3375 |
| language | English |
| last_indexed | 2024-03-11T10:22:27Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLOS Global Public Health |
| spelling | doaj.art-36dba366ee2347688b6b0d6e76b6e69f2023-11-16T05:56:09ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752023-01-01311e000200210.1371/journal.pgph.0002002Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022.Valerian MwendaLazarus OdenyShukri MohamedGladwell GathechaAnne KendagorDorcas KiptuiFlorence JagugaBeatrice MugiCaroline MithiKennedy OkindaDaniel MwaiDavid NjugunaWinnie AwuorRachel Kitonyo-DevotsuJane Rahedi Ong'ang'oTobacco use is a risk factor for many chronic health conditions. Quantifying burden of tobacco use among people with tobacco-related illnesses (TRI) can strengthen cessation programs. This study estimated prevalence, patterns and correlates of tobacco use among patients with TRI at four national referral hospitals in Kenya. We conducted a cross-sectional study among patients with five TRI (cancer, cardiovascular diseases, cerebrovascular disease, chronic obstructive pulmonary disease, and pulmonary tuberculosis) during January-July 2022. Cases identified from medical records were interviewed on socio-demographic, tobacco use and cessation information. Descriptive statistics were used to characterize patterns of tobacco use. Multiple logistic regression models were used to identify associations with tobacco use. We identified 2,032 individuals with TRI; 46% (939/2,032) had age ≥60 years, and 61% (1,241/2,032) were male. About 45% (923/2,032) were ever tobacco users (6% percent current and 39% former tobacco users). Approximately half of smokers and 58% of smokeless tobacco users had attempted quitting in the last month; 42% through cessation counselling. Comorbidities were present in 28% of the participants. Most (92%) of the patients had been diagnosed with TRI within the previous five years. The most frequent TRI were oral pharyngeal cancer (36% [725/2,032]), nasopharyngeal cancer (12% [246/2.032]) and lung cancer (10% [202/2,032]). Patients >60 years (aOR 2.24, 95% CI: 1.84, 2.73) and unmarried (aOR 1.21, 95% CI: 1.03, 1.42) had higher odds of tobacco use. Female patients (aOR 0.35, 95% CI: 0.30, 0.41) and those with no history of alcohol use (aOR 0.27, 95% CI: 0.23, 0.31), had less odds of tobacco use. Our study shows high prevalence of tobacco use among patients with TRI in Kenya, especially among older, male, less educated, unmarried, and alcohol users. We recommend tobacco use screening and cessation programs among patients with TRI as part of clinical care.https://doi.org/10.1371/journal.pgph.0002002 |
| spellingShingle | Valerian Mwenda Lazarus Odeny Shukri Mohamed Gladwell Gathecha Anne Kendagor Dorcas Kiptui Florence Jaguga Beatrice Mugi Caroline Mithi Kennedy Okinda Daniel Mwai David Njuguna Winnie Awuor Rachel Kitonyo-Devotsu Jane Rahedi Ong'ang'o Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022. PLOS Global Public Health |
| title | Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022. |
| title_full | Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022. |
| title_fullStr | Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022. |
| title_full_unstemmed | Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022. |
| title_short | Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022. |
| title_sort | prevalence patterns and factors associated with tobacco use among patients with priority tobacco related illnesses at four kenyan national referral hospitals 2022 |
| url | https://doi.org/10.1371/journal.pgph.0002002 |
| work_keys_str_mv | AT valerianmwenda prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT lazarusodeny prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT shukrimohamed prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT gladwellgathecha prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT annekendagor prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT dorcaskiptui prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT florencejaguga prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT beatricemugi prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT carolinemithi prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT kennedyokinda prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT danielmwai prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT davidnjuguna prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT winnieawuor prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT rachelkitonyodevotsu prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 AT janerahediongango prevalencepatternsandfactorsassociatedwithtobaccouseamongpatientswithprioritytobaccorelatedillnessesatfourkenyannationalreferralhospitals2022 |